SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-23-096002
Filing Date
2023-08-28
Accepted
2023-08-28 16:16:24
Documents
3
Group Members
5AM CO-INVESTORS II, L.P.5AM PARTNERS II, LLC5AM VENTURES II, L.P.5AM VENTURES VII, L.P.ANDREW J. SCHWABJOHN D. DIEKMANKUSH PARMARSCOTT M. ROCKLAGE

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2324813d1_sc13d.htm SC 13D 162285
2 EXHIBIT A tm2324813d1_ex99a.htm EX-99.A 13130
3 EXHIBIT D tm2324813d1_ex99d.htm EX-99.D 29887
  Complete submission text file 0001104659-23-096002.txt   207357
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Subject) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87830 | Film No.: 231215719
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 2ND STREET, SUITE 350 SAN FRANCISCO CA 94107
Business Address 501 2ND STREET, SUITE 350 SAN FRANCISCO CA 94107 (415) 993-8565
5AM Partners VII, LLC (Filed by) CIK: 0001873545 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D